Cargando…
Blood biomarker-based classification study for neurodegenerative diseases
As the population ages, neurodegenerative diseases are becoming more prevalent, making it crucial to comprehend the underlying disease mechanisms and identify biomarkers to allow for early diagnosis and effective screening for clinical trials. Thanks to advancements in gene expression profiling, it...
Autores principales: | Kelly, Jack, Moyeed, Rana, Carroll, Camille, Luo, Shouqing, Li, Xinzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567903/ https://www.ncbi.nlm.nih.gov/pubmed/37821485 http://dx.doi.org/10.1038/s41598-023-43956-4 |
Ejemplares similares
-
Genetic networks in Parkinson’s and Alzheimer’s disease
por: Kelly, Jack, et al.
Publicado: (2020) -
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
por: Kelly, Jack, et al.
Publicado: (2019) -
Biomarker-guided classification scheme of neurodegenerative diseases
por: Baldacci, Filippo, et al.
Publicado: (2016) -
Editorial: Blood Biomarkers of Neurodegenerative Diseases
por: Karikari, Thomas K., et al.
Publicado: (2022) -
Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
por: Lin, Chin-Hsien, et al.
Publicado: (2020)